Moderna Inc (NASDAQ:MRNA)
| 70.17 Delayed Data As of Oct 26 |  -0.29 / -0.41%Today’s Change | 15.52 Today|||52-Week Range 95.21 | +258.74% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 70.53 |
| Today’s open | 70.36 |
| Day’s range | 68.70 - 71.32 |
| Volume | 3,872,799 |
| Average volume (3 months) | 16,134,560 |
| Market cap | $27.8B |
Data as of 5:12pm ET, 10/26/2020
Growth & Valuation
| Earnings growth (last year) | +68.63% |
| Earnings growth (this year) | +12.46% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | -55.42% |
| P/E ratio | NM |
| Price/Sales | 107.47 |
| Price/Book | 20.18 |
Competitors
Data as of 4:00pm ET, 10/26/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $60.2M |
| Annual profit (last year) | -$514.0M |
| Net profit margin | -853.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
